High-level amplification of MYC and MYCN genes are also observed in GBM [11,50,51], and inhibition of Myc-induced glycolysis selectively killed MYC/MYCN-amplified patient-derived GBM tumor spheres and extended the survival of mice bearing MYCN-amplified PDX [49]. The gene discussed is MYC; the disease is neoplasm.